Biotechnology News

August 29, 2012

TORONTO--(BUSINESS WIRE)--The US market for reprocessed medical devices will continue to show strong growth, averaging almost 9 percent per year through 2017. This growth will be driven by budget-conscious hospitals.

August 29, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Data from multiple studies of Durata Therapeutics' investigational drug dalbavancin and of outpatient management of acute bacterial skin and soft tissue infection (abSSTI) will be presented at ICAAC.

August 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Stifel Nicolaus Healthcare conference in Boston. Timothy P. Clackson, Ph.D., president of research and development and chief...

August 29, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) today announced that Walter C. Herlihy, Ph.D., President and Chief Executive Officer, will be presenting at the upcoming Stifel Nicolaus Healthcare Conference in Boston. Dr....

August 29, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation announced that Nancy E. Pecota, Aradigm’s Vice President, Finance and CFO, will present an overview of the Company at the Stifel Nicolaus 2012 Healthcare Conference

August 29, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ:SNTS) today announced that Gerald T. Proehl, president and chief executive officer, will make presentations at the following investment conferences: Stifel Nicolaus Healthcare Conference on...

August 29, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will present at two upcoming conferences in September. Jane Wasman, Chief, Strategic Development and General Counsel, will present at the Baird 2012...

August 29, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Continues Negotiations with Amarantus

August 29, 2012

MUNICH--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only New one-year follow-up results from the global RE-LY AF registry, a multinational primary care registry, have been announced for the first time during the European Society...

August 29, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic: (OSE:DIAG) New CEO - progress in Alzheimer’s and Parkinson’s disease The interim report for the second quarter 2012 was approved by the Board of Directors on 28 August 2012. Please find...

August 28, 2012

HENDERSON, Nev. & WESTMINSTER, Colo.--(BUSINESS WIRE)--Spectrum Pharmaceuticals and Allos Therapeutics announce that FTC clears transaction for acquisition of all outstanding shares of common stock of Allos by Spectrum.

August 28, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics is moving its R&D lab from California to North Carolina. This consolidation has been considered for quite some time, but was slowed by the poor real estate market.

August 28, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Morgan Stanley Global Healthcare...

August 28, 2012

PROVIDENCE, R.I.--(BUSINESS WIRE)--Tech Collective launches first award program in Rhode Island exclusively for individuals and innovators working in the biosciences. Nominations due: September 24th. Applications due: Oct. 1st.

August 28, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OmniGuide Inc. announces the closing of a $35 million non-dilutive financing with an affiliate of OrbiMed Advisors LLC.

August 28, 2012

CONCORD, Mass.--(BUSINESS WIRE)--Patent Litigator John Hamann Joins Hamilton Brook Smith Reynolds

August 28, 2012

ZURICH & TORONTO--(BUSINESS WIRE)--EBD Group, the leading partnering firm for the life science industry, and Generic Pharma 2.0 today announced Pharma Meetings, a meeting planning platform to facilitate engagement among attendees and...

August 28, 2012

SAN FRANCISCO--(BUSINESS WIRE)--ClinStar Execs Leon Dzivinsky and Richard Koenig to Examine How Clinical Study Start-Up Timelines Compare in Emerging Markets and How Biopharm Can Mitigate Risks and Reduce Timelines in Russia

August 28, 2012

DENVER--(BUSINESS WIRE)--Anova Cancer Care is one of only three radiosurgery centers in the U.S. chosen to participate in a landmark comparative effectiveness study to determine the best treatments for prostate cancer.

August 28, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech, the Midwest’s premier data center operator, congratulates Jason Yaeger, Director of Operations, who has received the 2012 Crain’s CIO Award presented by Crain’s Detroit Business. The winners of the...

August 28, 2012

EXTON, Penn.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that despite the considerable heterogeneity across different European countries,...

August 28, 2012

LOS ANGELES--(BUSINESS WIRE)--AHF to take a leading role in HIV/AIDS research: Respected AIDS researcher and clinician Dr. Otto O. Yang to serve as the inaugural Scientific Director.

August 28, 2012

ST. PAUL, Minn. & MUNICH--(BUSINESS WIRE)--St. Jude Medical's EnligHTN renal denervation technology for hypertension demonstrated a safe and rapid 28 point reduction of systolic blood pressure after 1 month that remained stable at 3 months....

August 28, 2012

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Manhattan Scientifics (OTCBB: MHTX) announced today that its Senior Scientific subsidiary has named Steven C. Miller, Ph.D. to the position of Chief Commercialization Officer. Senior Scientific is developing...

August 28, 2012

--(BUSINESS WIRE)--Long-distance runner C.J. Howard lost his lower left leg to cancer, discovered rock climbing, and used additive manufacturing technology to make himself a one-of-a-kind custom prosthetic.

August 28, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Top-performing health economics groups actively provide input to the clinical teams, according to a new study from Cutting Edge Information.

August 28, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Interim report JANUARY – JUNE 2012 For the second quarter April - June · Net sales for the quarter were SEK 28.7 million (24.4), an increase of 17.6 percent compared to the same period last year. (...

August 28, 2012

CAMBRIDGE, Mass. & ST. LOUIS--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today they have formed a strategic alliance to advance biological technologies in the field of agriculture...

August 28, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced top-line results from a Phase II...

August 28, 2012

TORONTO--(BUSINESS WIRE)--The European soft tissue repair device market will see procedure volume growth driven largely by an aging population, while also experiencing steady downward pressure on average selling prices.

August 28, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) announced today that it has entered into a definitive agreement to acquire the global rights to Axial Biotech’s ScoliScore™ Adolescent Idiopathic Scoliosis (AIS) Prognostic Test for a...

August 28, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research released a site-level reference booklet that highlights the qualifications, training, documentation and safety of clinical trials.

August 28, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics CEO Paul Edick will present a company overview at the 2012 BioCentury NewsMakers in the Biotech Industry conference in New York City on Sept 7 at 9 AM.

August 28, 2012

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal 2013 sales and earnings estimates. Based on the Company’s business planning and budgeting...

August 28, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--With CE Mark Approval for DESyne BD Novolimus Eluting CSS, Elixir Medical Becomes First Company To Offer Both Durable and Biodegradable Polymer Platforms for DES.

August 28, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced data from a preclinical study showed that treatment with Glial Growth Factor 2 (GGF2) improved erectile function in an animal model following a cavernous nerve (CN...

August 28, 2012

NEW HAVEN, Conn.--(BUSINESS WIRE)--Covidien received 510(k) clearance from the FDA for the iDrive™ Ultra powered stapling system. This stapling system is the only fully powered, reusable, battery-operated endoscopic surgical stapler.

August 28, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the ThinkEquity 9th Annual Growth Conference in New York on Wednesday, September 12, 2012 at 11:15 AM...

August 28, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Recognized with 2012 Innovation of the Year by the Society of Laparoendoscopic Surgeons

August 28, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex to Present at the 2012 Morgan Stanley Global Healthcare Conference

August 28, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on September 7, 2012 at the NewsMakers in the Biotech Industry Conference in New York City. The GTx presentation will begin...

August 28, 2012

SOLNA, Sweden & ANTONY, France--(BUSINESS WIRE)--Aerocrine AB (STO:AERO.B) and Stallergenes S.A (Euronext Paris CAC small) today announce the signing of an exclusive multi-year distribution agreement for Aerocrine’s airway inflammation...

August 28, 2012

LONDON--(BUSINESS WIRE)--AstraZeneca today announced that ticagrelor, an oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised “Guidelines on the Management of Acute Myocardial...

August 27, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved StribildTM (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil...

August 27, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--On August 22, 2012, Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) received a notice from NYSE Regulation, Inc. on behalf of NYSE MKT LLC (the “NYSE MKT”) providing notification that...

August 27, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced that John S. Yu, MD, Interim Chief Executive Officer, will present a corporate overview and business update at the BioCentury and...

August 27, 2012

SAN ANTONIO--(BUSINESS WIRE)--The first patient has dosed in the first clinical study with ASC-101 underway at MDACC. ASC-101 enhances engraftment of cord blood and neutrophil recovery thru fucosylation of cell surface proteins.

August 27, 2012

WASHINGTON--(BUSINESS WIRE)--The Biofuels Producers Coordinating Council today wrote President Obama to urge caution on waiving the Renewable Fuel Standard.

August 27, 2012

ST. LOUIS, Mo.--(BUSINESS WIRE)--Scientists from Certara are participating in the19th Annual EuroQSAR Symposia in Vienna, Austria, August 26-30, 2012, including a key scientific talk and presentation of five posters.